Genital Herpes Treatment Drugs Market Insights, Global Outlook and Forecast 2022-2028
Genital Herpes Treatment Drugs Market Insights, Global Outlook and Forecast 2022-2028
Genital Herpes Treatment Drugs Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD.
The latest research study released by Market IntelliX evaluates market size and forecasts of Genital Herpes Treatment Drugs in Global, including the following market information:
Global Genital Herpes Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Genital Herpes Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acyclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Genital Herpes Treatment Drugs include AstraZeneca, Plc., Apotheca, Inc., Asahi Kasei Pharma Corporation, Carlsbad Technology, Inc., GlaxoSmithkline, Plc., Mylan N.V., Novartis AG., Merck & Co., Inc. and Teva Pharmaceutical Industries Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Genital Herpes Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Genital Herpes Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Acyclovir
Famciclovir
Valacyclovir
Global Genital Herpes Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Genital Herpes Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genital Herpes Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Genital Herpes Treatment Drugs revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
AstraZeneca, Plc.
Apotheca, Inc.
Asahi Kasei Pharma Corporation
Carlsbad Technology, Inc.
GlaxoSmithkline, Plc.
Mylan N.V.
Novartis AG.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Zydus Pharmaceuticals, Inc.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Genital Herpes Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genital Herpes Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genital Herpes Treatment Drugs Overall Market Size
2.1 Global Genital Herpes Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Genital Herpes Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genital Herpes Treatment Drugs Players in Global Market
3.2 Top Global Genital Herpes Treatment Drugs Companies Ranked by Revenue
3.3 Global Genital Herpes Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Genital Herpes Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genital Herpes Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genital Herpes Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Genital Herpes Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Genital Herpes Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Genital Herpes Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Acyclovir
4.1.3 Famciclovir
4.1.4 Valacyclovir
4.2 By Type - Global Genital Herpes Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genital Herpes Treatment Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Genital Herpes Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Genital Herpes Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Genital Herpes Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Genital Herpes Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Genital Herpes Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Genital Herpes Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Genital Herpes Treatment Drugs Revenue, 2017-2028
6.3.2 US Genital Herpes Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Genital Herpes Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Genital Herpes Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.3 France Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Genital Herpes Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Genital Herpes Treatment Drugs Revenue, 2017-2028
6.5.2 China Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Genital Herpes Treatment Drugs Market Size, 2017-2028
6.5.6 India Genital Herpes Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Genital Herpes Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Genital Herpes Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Genital Herpes Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Genital Herpes Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Genital Herpes Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Genital Herpes Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Genital Herpes Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca, Plc.
7.1.1 AstraZeneca, Plc. Corporate Summary
7.1.2 AstraZeneca, Plc. Business Overview
7.1.3 AstraZeneca, Plc. Genital Herpes Treatment Drugs Major Product Offerings
7.1.4 AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca, Plc. Key News
7.2 Apotheca, Inc.
7.2.1 Apotheca, Inc. Corporate Summary
7.2.2 Apotheca, Inc. Business Overview
7.2.3 Apotheca, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.2.4 Apotheca, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Apotheca, Inc. Key News
7.3 Asahi Kasei Pharma Corporation
7.3.1 Asahi Kasei Pharma Corporation Corporate Summary
7.3.2 Asahi Kasei Pharma Corporation Business Overview
7.3.3 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Major Product Offerings
7.3.4 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Asahi Kasei Pharma Corporation Key News
7.4 Carlsbad Technology, Inc.
7.4.1 Carlsbad Technology, Inc. Corporate Summary
7.4.2 Carlsbad Technology, Inc. Business Overview
7.4.3 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.4.4 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Carlsbad Technology, Inc. Key News
7.5 GlaxoSmithkline, Plc.
7.5.1 GlaxoSmithkline, Plc. Corporate Summary
7.5.2 GlaxoSmithkline, Plc. Business Overview
7.5.3 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Major Product Offerings
7.5.4 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithkline, Plc. Key News
7.6 Mylan N.V.
7.6.1 Mylan N.V. Corporate Summary
7.6.2 Mylan N.V. Business Overview
7.6.3 Mylan N.V. Genital Herpes Treatment Drugs Major Product Offerings
7.6.4 Mylan N.V. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 Mylan N.V. Key News
7.7 Novartis AG.
7.7.1 Novartis AG. Corporate Summary
7.7.2 Novartis AG. Business Overview
7.7.3 Novartis AG. Genital Herpes Treatment Drugs Major Product Offerings
7.7.4 Novartis AG. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 Novartis AG. Key News
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Corporate Summary
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.8.4 Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.8.5 Merck & Co., Inc. Key News
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News
7.10 Zydus Pharmaceuticals, Inc.
7.10.1 Zydus Pharmaceuticals, Inc. Corporate Summary
7.10.2 Zydus Pharmaceuticals, Inc. Business Overview
7.10.3 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.10.4 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2017-2022)
7.10.5 Zydus Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Genital Herpes Treatment Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|